CHGCY:OTCMKTS
Chugai Pharmaceutical ADR
$19.16
arrow_downward
-0.21%(-0.040) 1D
Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCY...
Open
$19.36
High
$19.43
Low
$18.98
Mkt. cap
10.11T
Avg. vol.
297.78K
Volume
327.36K
52-wk high
$34.84
52-wk low
$18.98
Beta
0.56
Shares outstanding
3.36B
No. of employees
5K
Open
$19.36
High
$19.43
Low
$18.98
Mkt. cap
10.11T
Avg. vol.
297.78K
Volume
327.36K
52-wk high
$34.84
52-wk low
$18.98
Beta
0.56
Shares outstanding
3.36B
No. of employees
5K
News stories
From web sources and news partners
AD HOC NEWS
·
22 hours ago
Citi keeps Buy rating for Chugai Pharmaceutical stock at JPY 11,100.00
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical ADR
CEOOsamu Okuda
Employees5.1K
FoundedMar 10, 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp